Zobrazeno 1 - 4
of 4
pro vyhledávání: '"N. Lybimova"'
Autor:
E. Kalashnikova, R. Raupov, N. Lybimova, E. Kuchinskaya, O. Kalashnikova, V. Chasnyk, T. Kornishina, L. Snegireva, E. Gaidar, V. Masalova, E. Isupova, M. Kaneva, M. Dubko, T. Likhacheva, L. Sorokina, M. Kostik
Publikováno v:
Annals of the Rheumatic Diseases. 81:997.2-997
Backgroundjuvenile systemic lupus erythematosus (jSLE) is the most frequent pediatric connective tissue disease with multiorgan involvement and different outcomes and prognosis. Corticosteroids remain the base treatment option and steroid-sparing tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d25bc1718a3b214f64d267e38a4581b
https://doi.org/10.1136/annrheumdis-2022-eular.4061
https://doi.org/10.1136/annrheumdis-2022-eular.4061
Autor:
Evgeny N. Suspitsin, R. Raupov, E. Kalashnikova, N. Lybimova, M. Kostik, E. Kuchinskaya, A. Kosmin, R. Mulkidzhan
Publikováno v:
Annals of the Rheumatic Diseases. 80:246.1-247
Background:the role of interferon pathways in the pathogenesis of systemic lupus erythematosus (SLE) has been proven over the past years. Existing data suggest that interferon score (IFN I score) may serve as a useful marker of disease activity and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14447166b9ddce057cb3091158eb56e7
https://doi.org/10.1136/annrheumdis-2021-eular.1956
https://doi.org/10.1136/annrheumdis-2021-eular.1956
Publikováno v:
Annals of the Rheumatic Diseases. 80:927.3-928
Background:Immunosuppressive drugs, decreased vaccine coverage, aberrant immunity might be factors of low anti-vaccine antibodies in JIA patients.Objectives:The study aimed to evaluate risk factors of non-protective levels of antibodies against measl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8e014209005152f1babe7dad0ea1b1b
https://doi.org/10.1136/annrheumdis-2021-eular.503
https://doi.org/10.1136/annrheumdis-2021-eular.503
Autor:
R. Raupov, N. Lybimova, Susanna M. Kharit, M. Kostik, Olga V. Goleva, M. Kaneva, Irina V. Fridman
Publikováno v:
Annals of the Rheumatic Diseases. 79:827.1-828
Background:Patients with juvenile idiopathic arthritis (JIA) may have lower protective levels of anti-vaccine antibodies due to high inflammatory activity, interrupted or incomplete vaccination schedule, and due to using of immune-modulating drugs, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d352955ee7dc59d34e7c990c5e3078f
https://doi.org/10.1136/annrheumdis-2020-eular.6072
https://doi.org/10.1136/annrheumdis-2020-eular.6072